Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction

Respiratory Medicine

Volumn 100, Issue 8, 2006, Pages 1415-1422

  Calabrese, Cecilia ^a   Bocchino, Vincenzo ^b   Vatrella, Alessandro ^c   Marzo, Carlo ^a   Guarino, Carmine ^a   Mascitti, Sergio ^a   Tranfa, Carmelindo M E ^a   Cazzola, Mario ^d   Micheli, Pietro ^e   Caputi, Mario ^a   Marsico, Serafino A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b MONALDI HOSPITAL   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d CARDARELLI HOSPITAL   (Italy)

^e AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Angiogenesis; COPD; Integrin v 3; Smoke; Vascular endothelial growth factor

Indexed keywords

COLLAGEN TYPE 4; CORTICOSTEROID; MONOCLONAL ANTIBODY; VASCULOTROPIN; VITRONECTIN RECEPTOR;

ADULT; AIRWAY OBSTRUCTION; ANGIOGENESIS; ARTICLE; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; LUNG BLOOD VESSEL; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYMPTOM;

BIOPSY; BRONCHI; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTEGRIN ALPHAVBETA3; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; SMOKING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITAL CAPACITY;

EID: 33745368689     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.11.009     Document Type: Article

References (32)

1. Saetta M., Turato G., Maestrelli P., Mapp C.E., and Fabbri L.M. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 1304-1309
2. Hogg J.C., Chu F., Utokaparch S., et al. The nature of small airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 2645-2653
3. Charan N.B., Baile E.M., and Paré P.D. Bronchial vascular congestion and angiogenesis. Eur Respir J 10 (1997) 1173-1180
4. Li X., and Wilson J.W. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 156 (1997) 229-233
5. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 56 (2001) 902-906
6. Heeschen C., Jang J.J., and Weis M. Nicotine stimulates angiogenesis and promote tumor growth and atherosclerosis. Nature Med 7 (2001) 833-839
7. Fontanini G., Vignati S., Lucchi M., et al. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer 75 (1997) 1295-1301
8. Keith R.L., Miller Y.E., Gemmill R.M., et al. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res 6 (2000) 1616-1625
9. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237 (1999) 1-30
10. Varner J.A., Brooks P.C., and Cheresh D.A. The integrin αvβ3: angiogenesis and apoptosis. Cell Adhes Commun 3 (1995) 367-374
11. Max R., Gerritsen R.R., Nooijen P.T., et al. Immunohistochemical analysis of integrin alphavβ3 expression on tumor-associated vessels of human carcinomas. Int J Cancer 71 (1997) 320-324
12. Bocchino V., Bertorelli G., Zanini A., et al. Integrin αvβ3 is increased in the airways of atopic asthmatic patients [abstract]. Am J Resp Crit Care Med 163 (2001) A785
13. Bizova T.V., Goldman C.K., Pampori N., et al. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell 6 (2000) 851-860
14. Liu Z.J., Snyder R., Soma A., et al. VEGF-A and αvβ3 integrin synergistically rescue angiogenesis via N-Ras and P13-K signaling in human microvascular endothelial cells. FASEB J 17 (2003) 1931-1933
15. Pawels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Global initiative for of chronic obstructive lung disease (GOLD). NHLBI/WHO workshop report, 2001. Am J Respir Crit Care Med. 2001; 163: 1256-76.
16. Bocchino V., Bertorelli G., Zhuo X., et al. Short term treatment with low dose inhaled fluticasone propionate decreases the number of dendritic cells in asthmatic airways. Pulm Pharmacol Ther 10 (1997) 253-259
17. 2 on the airways of healthy subjects. Am J Resp Crit Care Med 156 (1997) 418-424
18. Kuwano K., Bosken C.H., Paré P.D., Bai T.R., Wiggs B.R., and Hogg J.C. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 148 (1993) 1220-1225
19. Hiroshima K., Iyoda A., Shibuya K., et al. Evidence of neoangiogenesis and an increase in the number of proliferating cells within the bronchial epithelium of smokers. Cancer 95 (2002) 1539-1545
20. Hashimoto M., Tanaka H., and Abe S. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 127 (2005) 965-972
21. Kanazawa H., Asai K., Hirata K., and Yoshikawa J. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 114 (2003) 413-414
22. Kranenburg A.R., de Boer W.I., Alagappan V.K., Sterk P.J., and Sharma H.S. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax 60 (2005) 106-113
23. Knox A.J., Stocks J., and Sutcliffe A. Angiogenesis and vascular endothelial growth factor in COPD. Thorax 60 (2005) 88-89
24. Nagai K., Betsuyaku T., Ito Y., Nasuhara Y., and Nishimura M. Decrease of vascular endothelial growth factor in macrophages from long-term smokers. Eur Respir J 25 (2005) 626-633
25. Kasahara Y., Tuder R.M., Taraseviciene-Stewart L., et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106 (2000) 1311-1319
26. Kasahara Y., Tuder R.M., Cool C.D., Linch D.A., Flores S.C., and Voelkel N.F. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 163 (2001) 737-744
27. Rybarczyk B.J., Lawrence S.O., and Simpson-Haidaris P.J. Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood 102 (2003) 4035-4043
28. Mousa S.A. Vitronectin receptors in vascular disorders. Curr Opin Invest Drugs 3 (2002) 1191-1195
29. Baluk P., Bowden J.J., Lefevre P.M., and McDonald D.M. Upregulation of substance P receptors in angiogenesis associated with chronic airway inflammation in rats. Am J Physiol 273 (1997) L565-L571
30. Kwan M.L., Gòmez A.D., Baluk P., Hashizume H., and McDonald D.M. Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P. Am J Physiol Lung Cell Mol Physiol 280 (2001) L286-L297
31. Di Stefano A., Maestrelli P., Roggeri A., et al. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 149 (1994) 803-810
32. Tormanem K.R., Uller L., Persson C.G.A., and Erjefalt J.S. Allergen exposure of mouse airways evokes remodelling of both bronchi and large pulmonary vessels. Am J Respir Crit Care Med 171 (2005) 19-25